Photo caption: The Food and Drug Administration approved Cobenfy, a twice-a-day medication that is a new kind of treatment for...
side effects
Image caption: By the end of the trial, 60% of patients were able to effectively stop Donanemab treatment. Image credit:...
Photo caption: A sign is pictured at the Goizueta Alzheimer's Disease Research Center, at the Emory University Brain Health Center...
Image credit: Keith Negley. Article by Jyoti Madhusoodanan. Scientific American - February 21, 2024. New drugs called antibody-drug conjugates help...
Image caption: A Parkinson’s patient in Nice, France, is prepped for a surgery to implant electrodes into the brain. The...
